Your session is about to expire
← Back to Search
Other
Total Contact Soft Cast for Diabetic Foot Ulcers
N/A
Recruiting
Led By Joseph Schuster, DPM
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Any adult with a diabetic foot ulcer
Be older than 18 years old
Must not have
Inability to be seen weekly or as needed
Persons lacking capacity to consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new type of cast for people with diabetes who have ulcers on their feet. They want to see if it is effective, easy to use, and safe.
Who is the study for?
Adults with diabetic foot ulcers can join this trial. It's not for those allergic to Calamine or Zinc oxide, who can't have their leg wrapped, or can't commit to weekly visits. Prisoners and individuals unable to consent are also excluded.
What is being tested?
The trial is testing the effectiveness of a total contact soft cast versus a Cam Boot on diabetic foot ulcers. It looks at how well patients tolerate each treatment, how easy they are to use, and their safety.
What are the potential side effects?
Potential side effects may include skin irritation due to materials in the casts or boots, discomfort from wearing them, and possible increased risk of infection if not monitored properly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have a diabetic foot ulcer.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I cannot attend weekly or as-needed appointments.
Select...
I am unable to make medical decisions for myself.
Select...
I cannot have my leg wrapped.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Complete Healing Rates
Secondary study objectives
Patient Compliance with Use of the Total Contact Soft Cast
Patient Complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Soft Cast without a Removable Cam BootExperimental Treatment1 Intervention
Patients with a foot, ankle, or lower leg ulcer (which we expect to be mostly diabetic foot ulcers) will be provided with a total contact soft cast.
Group II: Soft Cast with a Removable Cam BootExperimental Treatment2 Interventions
Patients with a foot, ankle, or lower leg ulcer (which we expect to be mostly diabetic foot ulcers) will be provided with a total contact soft cast with removable cam boot.
Group III: ConventionalActive Control1 Intervention
Patients with a foot, ankle, or lower leg ulcer (which we expect to be mostly diabetic foot ulcers) will use conventional offloading including total contact casting, removable cast boots (cam boots), CROW boots, bracing, AFO's, offloading shoes, insoles, padding, shoe modifications, crutches, wheelchairs, rollabout, and surgical correction.
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,439 Previous Clinical Trials
1,621,858 Total Patients Enrolled
Joseph Schuster, DPMPrincipal InvestigatorUniversity of Minnesota
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I cannot attend weekly or as-needed appointments.You are allergic to Calamine or Zinc oxide.I am unable to make medical decisions for myself.I have a diabetic foot ulcer.I cannot have my leg wrapped.
Research Study Groups:
This trial has the following groups:- Group 1: Conventional
- Group 2: Soft Cast with a Removable Cam Boot
- Group 3: Soft Cast without a Removable Cam Boot
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.